GUARDIAN  |  Business

Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026

Wegovy和Ozempic制造商预测2026年收入将大幅下降

Wegovy weight-loss treatments. Novo Nordisk predicts a 5-13% fall in sales despite its potential game-changer Wegovy weight-loss pill coming on to the market.

Wegovy weight-loss treatments. Novo Nordisk predicts a 5-13% fall in sales despite its potential game-changer Wegovy weight-loss pill coming on to the market.

2026-02-04  752词  中等
字体大小
Last year, Novo sales grew by 10% to 309bn Danish kroner (£36.6bn) “despite being a challenging year for the company”, according to Mike Doustdar, the chief executive. Profit before tax rose by 3% to 130.5bn kroner.

请登录后继续阅读完整文章

还没有账号？立即注册

成为会员后您将享受无限制的阅读体验，并可使用更多功能，了解更多

免责声明：本文来自网络公开资料，仅供学习交流，其观点和倾向不代表本站立场。